SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 26 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,925,009 | +3.9% | 9,007,000 | 0.0% | 0.05% | 0.0% |
| Q2 2023 | $15,327,332 | -12.2% | 9,007,000 | 0.0% | 0.05% | -14.8% |
| Q1 2023 | $17,447,371 | +3.8% | 9,007,000 | 0.0% | 0.05% | -5.3% |
| Q4 2022 | $16,802,227 | +12.2% | 9,007,000 | 0.0% | 0.06% | -5.0% |
| Q3 2022 | $14,980,000 | -30.4% | 9,007,000 | -47.0% | 0.06% | -34.1% |
| Q2 2022 | $21,534,000 | -3.7% | 17,007,000 | 0.0% | 0.09% | +2.2% |
| Q1 2022 | $22,352,000 | +60.3% | 17,007,000 | +78.9% | 0.09% | +58.9% |
| Q4 2021 | $13,948,000 | – | 9,507,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 53,865,000 | $101,127,280 | 3.93% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 88,657,000 | $165,397,613 | 3.42% |
| Boussard & Gavaudan Investment Management LLP | 11,898 | $21,871,538 | 2.42% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 38,394,000 | $71,834,226 | 1.71% |
| WOLVERINE ASSET MANAGEMENT LLC | 79,876,000 | $149,367,384 | 1.55% |
| CSS LLC/IL | 4,747,000 | $8,868,606 | 0.50% |
| Opti Capital Management, LP | 3,000,000 | $5,611,938 | 0.48% |
| Verition Fund Management LLC | 16,459,000 | $30,786,560 | 0.48% |
| Aequim Alternative Investments LP | 5,000,000 | $9,352,500 | 0.25% |
| MIZUHO SECURITIES USA LLC | 1,097,000 | $2,047,616 | 0.19% |